Von Hippel-Lindau Disease

A germline mutation in the Von-Hippel Lindau (VHL) gene predisposes carriers to development of abundantly vascularised tumours in the retina, cerebellum, spine, kidney, adrenal gland and pancreas. Most VHL patients die from the consequences of cerebellar haemangioblastoma or renal cell carcinoma. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hes, Frederik J, Höppener, Jo WM, Luijt, Rob B van der, Lips, Cornelis JM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837060/
https://www.ncbi.nlm.nih.gov/pubmed/20223044
http://dx.doi.org/10.1186/1897-4287-3-4-171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837060/
https://www.ncbi.nlm.nih.gov/pubmed/20223044
http://dx.doi.org/10.1186/1897-4287-3-4-171

Ejemplares similares